Mackay Shields LLC’s Array Biopharma Inc ARRY Stock Holding History

Mackay Shields LLC’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-141,821	Closed	-$6.57M	–	1561
2019 Q2	$6.57M	Buy	141,821 +79,964	+129%	+$2.25M	0.04%	439
2019 Q1	$1.51M	Sell	61,857 -300	-0.5%	-$6.25K	0.01%	842
2018 Q4	$886K	Sell	62,157 -18,143	-23%	-$275K	0.01%	978
2018 Q3	$1.22M	Buy	80,300 +12,800	+19%	+$196K	0.01%	831
2018 Q2	$1.13M	Sell	67,500 -2,000	-3%	-$31.8K	0.01%	919
2018 Q1	$1.13M	Buy	+69,500	New	+$1.11M	0.01%	950

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Mackay Shields LLC's ARRY Position: Q3 2019 in Review

Mackay Shields LLC sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 141,821 shares — an estimated $6.57M sold.

Mackay Shields LLC first reported a position in ARRY in Q1 2018 and held it in 6 quarters. The position peaked at $6.57M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Mackay Shields LLC reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Mackay Shields LLC sold 141,821 Array Biopharma Inc shares in Q3 2019, an estimated $6.57M.
Mackay Shields LLC first reported a position in Array Biopharma Inc in Q1 2018 and held it in 6 quarters.
Mackay Shields LLC's Array Biopharma Inc position peaked at $6.57M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Mackay Shields LLC's 13F filing for Q3 2019, filed 1 Nov 2019.